Exoria is a platform that performs high-resolution gel electrophoresis and, in the same run, delivers every resolved band as purified material in a 96-well plate. It's built on established electrophoretic methods — SDS-PAGE, capillary gel electrophoresis, and native fluorescence detection — combined and automated on a single instrument.
Sample is loaded at the top of a gel. A vertical field separates proteins by size (or by pI, or by mobility — three separation modes, one platform).
Resolved bands are held in stable positions. A perpendicular field then mobilizes each band along the horizontal axis, one at a time.
Each band arrives at its own well in a 96-well plate — purified material, ready for MS identification, immunoassay, or functional testing.
Isolate each peak, identify what it is, and test what it does.
Screen variants and select the right clone with purified material in hand.
Track degradation products through upstream and downstream development.
Characterize degradation pathways under stressed storage conditions.
Meet ICH Q6B expectations for purity and identity, from one instrument.
Match the innovator with variant-level structural and functional data.
Replace the 3–5 assays per variant with a single unified workflow.
Resolve and characterize stress-induced species from a single loading.
Early-access testing is open for select pharma and CDMO partners. Bring your hardest variant-isolation problem.